You are here
Navigated rTMS treatment of depression
Navigated rTMS is an increasingly popular treatment option for patients with major depression. It has been approved by the FDA since 2009, is CE certified for clinical use in the EU and is reimbursed by an increasing number of health care insurers. Still, there are a range of different rTMS protocols available to the clinician, and the TMS coil can be placed in the target region in many different ways. It is hence not surprising that results can vary significantly, and that best practices continue to be improved.
The current webinar presents the latest insights into how rTMS is best applied in the treatment of depression, and how MRI guided neuronavigation can be used to improve TMS targeting and clinical outcome. Two experts in the field will guide you through latest developments and share their insights. There will be ample room to ask questions.
In between both lectures, we will demonstrate our latest rTMS and MRI guided neuronavigation equipment, and teach you how to use the equipment successfully.
The webinar will take place using the Zoom platform, with a maximum of 100 participants that have registered upfront. You can register here using our online form from the Zoom platform. A few days before the webinar, you will receive the Zoom link to participate by email. Participation is free for everyone.
The times of the scheduled topics outlined below are according to Amsterdam time, which is Central European Summer Time (CEST) at the moment of writing.
|11.00-11.25h CEST||Paul Fitzgerald, Monash University, Melbourne, Australia||Improving the outcome of rTMS therapy in depression through personalization|
|11.25-11.50h CEST||Jord Vink, Brain Science Tools BV||Live demonstrations of neuronavigated rTMS equipment, coils and protocols|
|11.50-12.15h CEST||Bas Neggers, Brain Science Tools BV / UMC Utrecht, The Netherlands||
Tutorial on how to use MRI to guide rTMS treatment for depression, tinnitus, psychosis and parkinson's disease
Professor Paul Fitzgerald
Professor Paul Fitzgerald is Professor of Psychiatry at Epworth Healthcare / The Epworth Clinic and Director of The Epworth Centre for Innovation in Mental Health. He is also a Founder and Medical Director of TMS Australia (www.tmsaustralia.com.au).
Professor Fitzgerald is a world leading expert in Transcranial Magnetic Stimulation (TMS) and other forms of brain stimulation – he has conducted research with TMS for over 20 years and has run a series of clinical TMS programs in Australia for over 15 years. His primary research focus has been on the development of brain stimulation techniques and clinical trials evaluating these in a variety of disorders, most prominently depression, where he has published over 450 journal articles and book chapters. He set up and ran the first training program in Australia and has trained over 500 people since its inception.He is Psychiatric deputy editor for the journal ‘Brain Stimulation’ and is on the Editorial Boards of ‘Psychiatry Research’ and the ‘Australian and New Zealand Journal of Psychiatry’.
Bas Neggers (PhD)
As a scientist-entrepeneur, Bas Neggers combines leading the UMC spinoff company Brain Science Tools BV with performing cutting edge brain research at the UMC Utrecht. This unique combination allows him to bring his discoveries and innovations to the market and patient as effectively and quickly as possible.
At Brain Science Tools BV he acts as CSO and CTO. At UMC Utrecht he is employed at the imaging division as Associate Professor, and focuses on functional neuroimaging and neurostimulation methods development, neurocomputational modeling and the control of action preparation in healthy subjects and patients with several disorders.
His background is Bio- and Medical Physics (MSc) and Neuroscience (PhD).